About Transcription initiation factor IIA subunit 1
Transcription initiation factor IIA subunit 1 (GTF2A1) is a protein
from Homo sapiens identified by UniProt accession
P52655, 376 residues long.
MolForge cross-references it against 0 known binders and
123 disease associations.
Target properties
| Protein name | Transcription initiation factor IIA subunit 1 |
| UniProt accession | P52655 |
| Gene | GTF2A1 |
| Organism | Homo sapiens |
| Length | 376 residues |
| Molecular weight | — |
| EC numbers | — |
| Target class | UNCLASSIFIED |
| Subcellular location | — |
| Keywords | — |
Druggability
Target tractability assessment (Open Targets + pocket analysis). No approved drug
| Druggability tier | MEDIUM |
| Druggability score | — |
| Pocket score | — |
| Max clinical phase | — |
Disease associations (123)
Diseases linked to this target (Open Targets).
- HIV infection · score 0.58
- neutrophil count · score 0.48
- leukocyte count · score 0.46
- high density lipoprotein cholesterol measurement · score 0.46
- mean corpuscular hemoglobin · score 0.45
- mean corpuscular hemoglobin concentration · score 0.44
- neurodegenerative disease · score 0.43
- erythrocyte count · score 0.43
- apolipoprotein A 1 measurement · score 0.40
- myeloid white cell count · score 0.40
3D Structure (1)
Experimental (PDB) and predicted (AlphaFold) structures for this protein.
| Structure | Source | Method | Mean pLDDT | Resolution (Å) |
| AF-P52655-F1 | alphafold | PREDICTED | 55.62 | — |
Amino-acid sequence (376 residues)
MANSANTNTV PKLYRSVIED VINDVRDIFL DDGVDEQVLM ELKTLWENKL MQSRAVDGFH SEEQQLLLQV QQQHQPQQQQ HHHHHHHQQA QPQQTVPQQA QTQQVLIPAS QQATAPQVIV PDSKLIQHMN ASNMSAAATA ATLALPAGVT PVQQILTNSG QLLQVVRAAN GAQYIFQPQQ SVVLQQQVIP QMQPGGVQAP VIQQVLAPLP GGISPQTGVI IQPQQILFTG NKTQVIPTTV AAPTPAQAQI TATGQQQPQA QPAQTQAPLV LQVDGTGDTS SEEDEDEEED YDDDEEEDKE KDGAEDGQVE EEPLNSEDDV SDEEGQELFD TENVVVCQYD KIHRSKNKWK FHLKDGIMNL NGRDYIFSKA IGDAEW
Explore Transcription initiation factor IIA subunit 1 with MolForge
Find binders, run structure-based screening, and map this target across
diseases and approved drugs with our AI-powered platform.
Browse all targets